Table of Contents Author Guidelines Submit a Manuscript
Biochemistry Research International
Volume 2013, Article ID 506731, 8 pages
http://dx.doi.org/10.1155/2013/506731
Research Article

miR-149 Inhibits Non-Small-Cell Lung Cancer Cells EMT by Targeting FOXM1

1Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
2Department of Oncology, The Second Affiliated Hospital of Nanjing Medical University, Nanjing 210011, China

Received 4 March 2013; Revised 19 April 2013; Accepted 19 April 2013

Academic Editor: Vladimir Uversky

Copyright © 2013 Yang Ke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Gao, L. T. Vahdat, S. Wong, J. C. Chang, and V. Mittal, “Microenvironmental regulation of epithelial-mesenchymal transitions in cancer,” Cancer Research, vol. 72, no. 19, pp. 4883–4889, 2012. View at Publisher · View at Google Scholar
  2. M. A. Kim, H. S. Lee, H. E. Lee, J. H. Kim, H. K. Yang, and W. H. Kim, “Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma,” Histopathology, vol. 54, no. 4, pp. 442–451, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. N. S. Nagathihalli and N. B. Merchant, “Src-mediated regulation of E-cadherin and EMT in pancreatic cancer,” Frontiers in Bioscience, vol. 17, pp. 2059–2069, 2012. View at Google Scholar
  4. J. Fuxe and M. C. Karlsson, “TGF-beta-induced epithelial-mesenchymal transition: a link between cancer and inflammation,” Seminars in Cancer Biology, vol. 22, pp. 455–461, 2012. View at Google Scholar
  5. R. Mallick, S. Patnaik, and S. Yendamuri, “MicroRNAs and lung cancer: biology and applications in diagnosis and prognosis,” Journal of Carcinogenesis, vol. 9, article no. 8, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. V. Zaninovic, T. Zamora, and K. Tajima, “Origins of T-cell leukaemia virus,” Nature, vol. 344, no. 6264, p. 299, 1990. View at Google Scholar · View at Scopus
  7. S. J. Pan, S. K. Zhan, B. G. Pei, Q. F. Sun, L. G. Bian, and B. M. Sun, “MicroRNA-149 inhibits proliferation and invasion of glioma cells via blockade of AKT1 signaling,” International Journal of Immunopathology and Pharmacology, vol. 25, pp. 871–881, 2012. View at Google Scholar
  8. J. Koshiol, M. Rotunno, D. Consonni et al., “Chronic obstructive pulmonary disease and altered risk of lung cancer in a population-based case-control study,” PLoS ONE, vol. 4, no. 10, Article ID e7380, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Angulo, E. Lecuona, and J. I. Sznajder, “Role of MicroRNAs in lung disease,” Archivos de Bronconeumología, vol. 48, pp. 325–330, 2012. View at Google Scholar
  10. G. P. Gupta and J. Massagué, “Cancer Metastasis: building a Framework,” Cell, vol. 127, no. 4, pp. 679–695, 2006. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Y. Lin, S. L. Yu, and P. C. Yang, “MicroRNA in lung cancer,” British Journal of Cancer, vol. 103, no. 8, pp. 1144–1148, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. C. C. Solomides, B. J. Evans, J. M. Navenot, R. Vadigepalli, S. C. Peiper, and Z. X. Wang, “MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis,” Acta Cytologica, vol. 56, pp. 645–654, 2012. View at Google Scholar
  13. Y. K. Zhang, W. Y. Zhu, J. Y. He et al., “miRNAs expression profiling to distinguish lung squamous-cell carcinoma from adenocarcinoma subtypes,” Journal of Cancer Research and Clinical Oncology, vol. 138, no. 10, pp. 1641–1650, 2012. View at Google Scholar
  14. L. He, J. M. Thomson, M. T. Hemann et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Cao, M. Seike, C. Soeno et al., “MiR-23a regulates TGF-β-induced epithelial-mesenchymal transition by targeting E-cadherin in lung cancer cells,” International Journal of Oncology, vol. 41, no. 13, pp. 869–875, 2012. View at Publisher · View at Google Scholar
  16. X. Liu, L. F. Sempere, H. Ouyang et al., “MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors,” Journal of Clinical Investigation, vol. 120, no. 4, pp. 1298–1309, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Brabletz and T. Brabletz, “The ZEB/miR-200 feedback loop-a motor of cellular plasticity in development and cancer?” EMBO Reports, vol. 11, no. 9, pp. 670–677, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Li, Y. Wang, J. Luo et al., “miR-134 inhibits epithelial to mesenchymal transition by targeting FOXM1 in non-small cell lung cancer cells,” FEBS Letters, vol. 586, no. 20, pp. 3761–3765, 2012. View at Publisher · View at Google Scholar
  19. J. Zhang, Y. F. Liu, and Y. Gan, “Lack of association between miR-149 C>T polymorphism and cancer susceptibility: a meta-analysis based on 4,677 cases and 4,830 controls,” Molecular Biology Reports, vol. 39, no. 9, pp. 8749–8753, 2012. View at Publisher · View at Google Scholar
  20. Y. Wang, X. Zheng, Z. Zhang et al., “MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer,” PLoS ONE, vol. 7, Article ID e41693, 2012. View at Publisher · View at Google Scholar
  21. D. Li, P. Chen, X. Y. Li et al., “Grade-specific expression profiles of miRNAs/mRNAs and docking study in human grade I-III astrocytomas,” OMICS, vol. 15, no. 10, pp. 673–682, 2011. View at Publisher · View at Google Scholar
  22. L. Jin, W. L. Hu, C. C. Jiang et al., “MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma,” Proceedings of the National Academy of Sciences of the United States of America, vol. 108, no. 38, pp. 15840–15845, 2011. View at Publisher · View at Google Scholar
  23. Z. Luo, L. Zhang, Z. Li et al., “An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma,” BMC Medical Genomics, vol. 5, p. 3, 2012. View at Publisher · View at Google Scholar
  24. Y. Wang, L. Wen, S. H. Zhao, Z. H. Ai, J. Z. Guo, and W. C. Liu, “FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients,” Lung Cancer, vol. 79, pp. 173–179, 2013. View at Google Scholar
  25. M. K. Hui, K. W. Chan, J. M. Luk et al., “Cytoplasmic Forkhead box M1 (FoxM1) in esophageal squamous cell carcinoma significantly correlates with pathological disease stage,” World Journal of Surgery, vol. 36, no. 1, pp. 90–97, 2012. View at Publisher · View at Google Scholar
  26. J. Millour, D. Constantinidou, A. V. Stavropoulou et al., “FOXM1 is a transcriptional target of ERα and has a critical role in breast cancer endocrine sensitivity and resistance,” Oncogene, vol. 29, no. 20, pp. 2983–2995, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Y. Koo, K. W. Muir, and E. W. Lam, “FOXM1: from cancer initiation to progression and treatment,” Biochimica et Biophysica Acta, vol. 1819, pp. 28–37, 2012. View at Google Scholar
  28. M. Priller, J. Pöschl, L. Abrão et al., “Expression of FoxM1 is required for the proliferation of medulloblastoma cells and indicates worse survival of patients,” Clinical Cancer Research, vol. 17, no. 21, pp. 6791–6801, 2011. View at Publisher · View at Google Scholar